Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound

BJU International

Volumn 102, Issue 4, 2008, Pages 452-458

  Cirillo, Stefano ^a,d   Petracchini, Massimo ^a   D'Urso, Leonardo ^b   Dellamonica, Patrizia ^a   Illing, Rowland ^c   Regge, Daniele ^a   Muto, Giovanni ^b  

^a Surgical Oncology   (Italy)

^b S GIOVANNI BOSCO HOSPITAL   (Italy)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Magnetic resonance imaging; Prostate cancer; PSA; Residual neoplasm; Spectroscopy; Transrectal high intensity focused ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MINIMAL RESIDUAL DISEASE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZATION; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 47749086745     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07633.x     Document Type: Article

References (30)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003 22 (Suppl. 1 3 12
2. Shibata A, Whittemore AS. Prostate cancer incidence and mortality in the United States and the United Kingdom. J Natl Cancer I 2001 93 : 1109 10
3. Grubb RL, Vardi IY, Bhayani SB, Kibel AS. Minimally invasive approaches to localized prostate carcinoma. Hematol Oncol Clin North Am 2006 20 : 879 95
4. Rewcastel JC. High intensity focused ultrasound for prostate cancer: a review of the scientific foundation, technology and clinical outcomes. Technol Cancer Res Treat 2006 5 : 619 25
5. Illing R, Emberton M. The Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer. Expert Rev Med Devices 2006 3 : 717 29
6. Aus G. Current status of HIFU and cryotherapy in prostate cancer - a review. Eur Urol 2006 50 : 927 34
7. Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004 63 : 625 9
8. Uchida T, Illing RO, Cathcart PJ, Emberton M. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate? BJU Int 2006 98 : 537 9
9. Poissonnier L, Chapelon JY, Rouviere O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007 51 : 381 7
10. Roach M, Hanks G, Thames H et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006 65 : 965 74
11. Rouviere O, Lyonnet D, Raudrant A et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 2001 40 : 265 74
12. Rouviere O, Curiel L, Chapelon JY et al. Can color Doppler predict the uniformity of HIFU-induced prostate tissue destruction? Prostate 2004 60 : 289 97
13. Hricak H, Wang L, Wei DC et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004 100 : 2655
14. Rorvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L, Haukaas S. MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 1999 9 : 29 34
15. Wang L, Mullerad M, Chen HN et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004 232 : 133 9
16. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004 24 (Suppl. 1 167 80
17. Yu KK, Scheidler J, Hricak H et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999 213 : 481 8
18. Scheidler J, Hricak H, Vigneron DB et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic: imaging-clinicopathologic study. Radiology 1999 213 : 473 80
19. Ter Haar GR. High intensity focused ultrasound for the treatment of tumors. Echocardiography 2001 18 : 317 22
20. Madersbacher S, Kratzik C, Marberger M. Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. Ultrason Sonochem 1997 4 : 175
21. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991 145 : 984 7
22. Zakian KL, Eberhardt S, Hricak H et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging - initial results. Radiology 2003 229 : 241 7
23. Schiebler ML, Tomaszewski JE, Bezzi M et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989 172 : 131 7
24. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002 12 : 2294 302
25. UICC TNM. Classificazione dei tumori maligni, Sesta Edizione. Milano : Raffaello Cortina Editore, 2002 : 188 91
26. Kurhanewicz J, Vigneron DB, Hricak H et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 1996 200 : 489 96
27. Amsellem-Ouazana D, Younes P, Conquy S et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005 47 : 582
28. Agresti A. Categorical Data Analysis. Chichester : Wiley, 2002 : 70
29. Rouvière O, Souchon R, Salomir R, Gelet A, Chapelon JY, Lyonnet D. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. Eur J Radiol 2007 63 : 317 27
30. Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI Magn Reson Med 2005 53 : 249 55